Stockscreener 앱 받기
9.89
4.21%
0.40
시장 영업 전:
9.83
-0.06
-0.61%
Novavax Inc 주식(NVAX)의 최신 뉴스
Novavax, Inc. $NVAX Stock Position Lowered by Vanguard Group Inc. - MarketBeat
Novavax (NVAX) EVP Elaine O'Hara receives major RSU and option grants - Stock Titan
[Form 4] NOVAVAX INC Insider Trading Activity - Stock Titan
Novavax Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
NVAX: Pivoting to a partnership-driven model, the company targets profitability by 2028 with robust pipeline and deals - TradingView
Is Novavax, Inc. (NVAX) a Good Buy at the Moment? - Bitget
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - Yahoo Finance
NVAX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash - Stocktwits
Trading Systems Reacting to (NVAX) Volatility - Stock Traders Daily
Sanofi Takes Charge of Novavax COVID Vaccine, Mixed Financial Projections Ahead - StocksToTrade
Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue - Stocktwits
Novavax, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:NVAX) 2026-02-28 - Seeking Alpha
Novavax Stock Faces Uncertain Future Amid Low Revenue Guidance - StocksToTrade
Assessing Novavax (NVAX) Valuation After Surprise Q4 Profitability And New Pfizer Licensing Deal - Yahoo Finance
How The Novavax (NVAX) Story Is Shifting Toward Licensing Income And COVID Recalibration - Yahoo Finance
Novavax (NASDAQ:NVAX) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Novavax (NASDAQ:NVAX) Trading Down 9.8%Here's What Happened - MarketBeat
Why Novavax (NVAX) Shares Are Falling Today - Finviz
Novavax: The Bear Case Is Broken, But The Bull Case Needs More Proof (NASDAQ:NVAX) - Seeking Alpha
Novavax (NASDAQ:NVAX) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
Novavax, Inc. (NASDAQ:NVAX) Q4 2025 Earnings Call Transcript - Insider Monkey
H.C. Wainwright raises Novavax stock price target on guidance beat - Investing.com
NVAX: HC Wainwright & Co. Raises Price Target Amidst Buy Rating - GuruFocus
Novavax Stock Gains as Q4 Earnings & Sales Beat Estimates - Zacks Investment Research
NVAX Q4 Deep Dive: Partnership-Led Strategy and Pipeline Transition Shape Outlook - Finviz
Why Novavax (NVAX) Is Up 10.2% After Partnership-Fueled Return To Full-Year Profitability – And What's Next - Sahm
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
Decoding Novavax Inc (NVAX): A Strategic SWOT Insight - GuruFocus
Novavax Q4 Earnings Call Highlights - MarketBeat
Novavax (NASDAQ:NVAX) Posts Quarterly Earnings Results, Beats Expectations By $0.77 EPS - MarketBeat
What's Going On With Novavax Stock On Friday? - Bitget
NVV1.F Novavax, Inc. (XETRA) up 15.65% pre-market 27 Feb 2026: earnings catalyst - Meyka
Novavax Inc (NVAX) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... By GuruFocus - Investing.com Canada
Novavax (NVAX) Turns Profitable With US$440 Million TTM Net Income Challenging Bearish Views - simplywall.st
Novavax to Participate in Upcoming Investor Conferences - GuruFocus
Novavax raises revenue forecast on boost from vaccine deals, shares soar - marketscreener.com
Novavax jumps as Q4 profit, higher revenue, and partnership milestones highlight a pivot to licensing - Quiver Quantitative
Novavax (NVAX) Reports Strong Q4 2025 Revenue Growth and Strategic Partnerships - GuruFocus
Novavax outlook 2026 adjusted total revenue $230 mln$270 mln - marketscreener.com
Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals - marketscreener.com
COVID-19 Vaccine Maker Novavax Swings To Profit As Sales Climb - Benzinga
Why Is Novavax (NVAX) Stock Soaring Today - Yahoo Finance
Novavax’s stock soars on expected revenue jump from big pharma deals - The Business Journals
Novavax Q4 2025 slides: earnings beat fuels partnership transformation - Investing.com
Novavax Q4 2025 slides: earnings beat fuels partnership transformation By Investing.com - Investing.com South Africa
Novavax (NVAX) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - Stocktwits
Novavax Sees Unusually High Options Volume (NASDAQ:NVAX) - MarketBeat
Earnings call transcript: Novavax Q4 2025 earnings beat expectations, stock rises - Investing.com India
NVAX: 2025 revenue surged 65% to $1.1B, with strong partnerships and cost discipline fueling growth - TradingView
Novavax, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
NVAX: 2025 revenue surged 65% to $1.1B, with strong partnerships and cost discipline extending cash runway into 2028 - TradingView
Novavax (NASDAQ:NVAX) Sets New 52-Week High on Earnings Beat - MarketBeat
Novavax raises revenue forecast on boost from vaccine deals; shares soar - TradingView
Novavax (NVAX) Surges as Q4 Earnings Exceed Expectations - GuruFocus
Novavax stock hits 52-week high at 10.65 USD By Investing.com - Investing.com South Africa
Novavax stock hits 52-week high at 10.65 USD - Investing.com
Novavax (NVAX) Stock Beats Q4 Estimates, Raises 2026 Revenue Outlook - CoinCentral
Earnings Flash (NVAX) Novavax Posts Q4 Total Revenue $147.1M, vs. FactSet Est of $89.8M - marketscreener.com
Novavax stock gains after Q4 revenue beat (NVAX:NASDAQ) - Seeking Alpha
NVAX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
NOVAVAX ($NVAX) Releases Q4 2025 Earnings - Quiver Quantitative
Novavax shares subdued despite earnings, revenue beat - Investing.com
Novavax, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Novavax reports Q4 revenue of $147M, signs Pfizer deal - Investing.com
Novavax: Q4 Earnings Snapshot - marketscreener.com
Novavax (NASDAQ:NVAX) Surprises With Strong Q4 CY2025 - Yahoo Finance
Novavax Earnings Review: Q4 Summary - Benzinga
0.11%
6.00%
자본화:
|
볼륨(24시간):